Biostax Corp.
IMUNDelisted Feb 20, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001559356
Biostax Corp. was delisted on Feb 20, 2025; its insiders filed their last Form 4 on Feb 22, 2023; no institution reported holding it in 13F filings for Q2 2023; no superinvestor held it.
13F holders, Q2 2023
Institutional positions in Biostax Corp. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
IMUN is no longer listed, so this page shows Q2 2023. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 0
- 0 vs. Q1 2023
- Shares held
- 0
- 0 vs. Q1 2023
- Total value
- $0
- $0 vs. Q1 2023
- New holders
- 0
- 0 more added
- Sold out
- 0
- 0 more reduced
Holders and value by quarter
Institutions reporting IMUN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Biostax Corp.; share changes are against Q1 2023.
No institution reported holding IMUN in Q2 2023.